Gts Securities »

Carisma Therapeutics shares owned by Gts Securities

Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Carisma Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Carisma Therapeutics held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carisma Therapeutics by Gts Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $14k 50k 0.27
2025-06-30 $20k 50k 0.39

More positions owned by Gts Securities

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
Meta Platforms Cl A (META)
Ishares Tr China Lg-cap Etf (FXI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Netflix (NFLX)
Select Sector Spdr Tr Financial (XLF)

View all positions for Gts Securities

Top funds holding Carisma Therapeutics

Merck & Co
Vanguard Group
BlackRock
Renaissance Technologies
Geode Capital Management
State Street Corporation
Northern Trust
Gts Securities
Bridgeway Capital Management
Empowered Funds
Blodgett Wealth Advisors
Virtu Financial
Goldman Sachs Group
Dynamic Financial Group
Two Sigma Securities

View all funds holding Carisma Therapeutics